Firm Begins Testing Cannabis for Diabetic Nerve Pain

Ganjapreneur
By TG BranfaltAug 5, 2021, 10:07 am316 pts
Chester Springs, Pennsylvania-based Affinity Bio Partners has launched a clinical study to test the potential efficacy of cannabis for diabetic nerve pain. The company said an estimated 47% of patients diagnosed with diabetes have some peripheral neuropathy. The study is being conducted in partnership with the…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

New Hampshire Bill To Ease Psilocybin Penalties Advances Through House But Is Tabled In Senate 69

New York regulators expand marijuana recall after alleged ‘inversion’ 68

2 board members, including Kris Krane, resign from marijuana operator 4Front 68

Anacostia Organics: Cannabis with care in the capital 68

California Cannabis Excise Tax Hike Takes Effect as Consumers Face Mounting Cost-of-Living Crisis 66

Star signs and cannabis strains: July 2025 horoscopes 64

10 Alabama CBD Stores, Vape Shops Raided; 4 Hemp Businesses Sue State 63

Honoring LGBTQIA+ Cannabis Trailblazers: A Pride Month Reflection 61

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.